CRISPR therapy cuts bad cholesterol over 50% for a year
Published
AI-generated summary of the coverage listed below: A single-dose CRISPR treatment that deactivates the ANGPTL3 gene in the liver lowered LDL cholesterol by more than 50% for one year and reduced triglycerides by 47.8%.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
Who is covering this story
- Center (1): Mid-Day